Consent Decree For cGMP Violations Signed By OTC Firm MBI Distributing
This article was originally published in The Tan Sheet
Executive Summary
MBI Distributing has signed a consent decree with FDA in which it agrees to "cease manufacturing and distributing drugs until it corrects manufacturing deficiencies," the agency announced Nov. 29